Blood Screening Market size was over USD 3 billion in 2024 and is poised to reach USD 6.54 billion by the end of 2037, growing at around 6.3% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of blood screening is assessed at USD 3.15 billion.
The growth of the market can be attributed to the increased prevalence of chronic diseases, such as heart problems, chronic kidney disease, and others. To diagnose underlying chronic illnesses in the human body and proceed with timely treatment, blood screening has a huge role to play. According to the World Health Organization, globally, around 18 million people succumb to death from cardiovascular problems. Moreover, according to the Centers for Disease Control and Prevention, in recent times, nearly 415 million people had diabetes worldwide, and by 2040, over half a billion of the world’s population is likely to develop diabetes.
In addition to these, complications occurring in pregnancies and related preventive screening often require blood screening procedures, further bolstering market growth. They are required to plan the best course of treatment in a variety of situations. According to the World Health Organization, every day, over 810 women die of pregnancy and childbirth-related problems. Furthermore, the surge in the count of COVID-19 patients and other infectious diseases is expected to propel the industry growth.
Growth Drivers
Challenges
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
6.3% |
|
Base Year Market Size (2024) |
USD 3 billion |
|
Forecast Year Market Size (2037) |
USD 6.54 billion |
|
Regional Scope |
|
Technology (Nucleic Acid Testing, Rapid Tests, Western Blot Assay, ELISA, Next-Generation Sequencing)
The ELISA segment in the blood screening market is anticipated to hold the largest gain by the end of 2037. ELISA is a typical laboratory test, done to find antibodies in the blood. They are produced when the immune system of the body recognizes dangerous compounds, known as antigens. The segment growth is primarily attributed to the rising need for testing for COVID-19, and carrying out sexually transmitted diseases testing among the population around the world. As per the World Health Organization, globally, more than 1 million people have STDs. Moreover, as of July 2022, there were nearly 40 million HIV cases all over the world.
End Users (Hospitals, Clinical Laboratories)
Blood screening market from the hospital segment is attributed to holding the largest share of 55 % over the forecast period. As a large patient pool is being admitted to hospitals, owing to which the popularity of hospitals is being increased daily, it is anticipated to bring lucrative growth opportunities for the segment growth. Further, the growing cases of organ transplant surgeries in hospitals are other factors to drive the segment growth.
Our in-depth analysis of the global market includes the following segments:
|
Technology |
|
|
Product Type |
|
|
End User |
|
North American Market Forecast
The blood screening market in North America is projected to be the largest with a share of about 38% by the end of 2037. The higher demand for blood transfusion is forecasted to elevate the market growth in North America during the assessment period. Every year, around 21 million blood components are transfused in the United States. Further, the presence of a strong healthcare network in the region, along with the availability of supportive policies by regulatory bodies, is anticipated to contribute positively to the market's growth.
APAC Market Statistics
The Asia Pacific market is estimated to be the second largest, registering a share of about 25% by the end of 2037. The major factor that is attributed to creating a positive outlook for the market growth is the increasing spending capacity of opting for advanced medical facilities such as blood transfusion diagnostics along with the presence of a high number of medical facilities are also anticipated to hike the market growth further during the projected time frame in the region.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?